Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Polio Vaccine
Therapeutic Area : Undisclosed
Study Phase : Phase IV
Sponsor : Radboud University Medical Center
Deal Size : Inapplicable
Deal Type : Inapplicable
The Non-Specific Immunological Effects of Providing Oral Polio Vaccine to Seniors in Guinea-Bissau
Details : Undisclosed
Product Name : Undisclosed
Product Type : Vaccine
Upfront Cash : Inapplicable
February 20, 2024
Lead Product(s) : Polio Vaccine
Therapeutic Area : Undisclosed
Highest Development Status : Phase IV
Sponsor : Radboud University Medical Center
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Polio Vaccine
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Sponsor : World Health Organization
Deal Size : Inapplicable
Deal Type : Inapplicable
Use of mOPV1 in Routine Immunization in Pakistan.
Details : Undisclosed
Product Name : Undisclosed
Product Type : Vaccine
Upfront Cash : Inapplicable
August 07, 2020
Lead Product(s) : Polio Vaccine
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Sponsor : World Health Organization
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Polio Vaccine
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
OPV as Potential Protection Against COVID-19
Details : Undisclosed
Product Name : Undisclosed
Product Type : Vaccine
Upfront Cash : Inapplicable
June 24, 2020
Lead Product(s) : Polio Vaccine
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Polio Vaccine
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase IV
Sponsor : World Health Organization
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
March 26, 2019
Lead Product(s) : Polio Vaccine
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase IV
Sponsor : World Health Organization
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Polio Vaccine
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase III
Sponsor : Bill & Melinda Gates Foundation
Deal Size : Inapplicable
Deal Type : Inapplicable
A Study to Evaluate Immunogenicity of Intramuscular Full-Dose and Intradermal Fractional Dose of IPV
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
August 04, 2017
Lead Product(s) : Polio Vaccine
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase III
Sponsor : Bill & Melinda Gates Foundation
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Polio Vaccine
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase III
Sponsor : Bill & Melinda Gates Foundation
Deal Size : Inapplicable
Deal Type : Inapplicable
A Study to Evaluate Immunogenicity of Various Schedules of Inactivated Polio Vaccine
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
January 11, 2017
Lead Product(s) : Polio Vaccine
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase III
Sponsor : Bill & Melinda Gates Foundation
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Polio Vaccine
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase IV
Sponsor : Bill & Melinda Gates Foundation
Deal Size : Inapplicable
Deal Type : Inapplicable
A Study to Evaluate Safety and Immunogenicity of tOPV in 1 to 5 Years and at 6 Weeks of Age
Details : Undisclosed
Product Name : Undisclosed
Product Type : Vaccine
Upfront Cash : Inapplicable
October 20, 2015
Lead Product(s) : Polio Vaccine
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase IV
Sponsor : Bill & Melinda Gates Foundation
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Polio Vaccine
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase IV
Sponsor : World Health Organization | Centers for Disease Control and Prevention | National Institutes of Health
Deal Size : Inapplicable
Deal Type : Inapplicable
Polio End-game Strategies - Poliovirus Type 2 Challenge Study
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
July 15, 2014
Lead Product(s) : Polio Vaccine
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase IV
Sponsor : World Health Organization | Centers for Disease Control and Prevention | National Institutes of Health
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Polio Vaccine
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase IV
Sponsor : Pakistan Ministry of Health | Trust for Vaccines and Immunization, Pakistan | National Institutes of Health, Pakistan | Peshawar Medical College | World Health Organization | UNICEF | Bill & Melinda Gates Foundation
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Vaccine
Upfront Cash : Inapplicable
July 25, 2013
Lead Product(s) : Polio Vaccine
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase IV
Sponsor : Pakistan Ministry of Health | Trust for Vaccines and Immunization, Pakistan | National Institutes of Health, Pakistan | Peshawar Medical College | World Health Organization | UNICEF | Bill & Melinda Gates Foundation
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Polio Vaccine
Therapeutic Area : Undisclosed
Study Phase : Phase IV
Sponsor : World Health Organization | National Institutes of Health
Deal Size : Inapplicable
Deal Type : Inapplicable
IPV in Moderate to Severe Chronic Malnourished 9-12 Month Old Children in Karachi.
Details : Undisclosed
Product Name : Undisclosed
Product Type : Vaccine
Upfront Cash : Inapplicable
September 28, 2012
Lead Product(s) : Polio Vaccine
Therapeutic Area : Undisclosed
Highest Development Status : Phase IV
Sponsor : World Health Organization | National Institutes of Health
Deal Size : Inapplicable
Deal Type : Inapplicable